Clinical Evidence: The SURPASS Trial Program
Mounjaro was evaluated across the SURPASS clinical development program, encompassing more than 19,000 patients across 10 global phase 3 clinical trials. The pivotal head-to-head study, SURPASS-2 (Frías et al., New England Journal of Medicine2021; 385:503-515, DOI: 10.1056/NEJMoa2107519), evaluated 1,879 adults with type 2 diabetes inadequately controlled on metformin (≥ 1,500 mg/day) randomized to tirzepatide (5, 10, or 15 mg) or semaglutide 1.0 mg once weekly for 40 weeks:
| Treatment Arm | Cohort ($n$) | Mean HbA1c Reduction | Mean Weight Change | HbA1c < 5.7% Rate |
|---|---|---|---|---|
| Tirzepatide 5 mg | 470 | -2.01% (difference vs semag -0.15%) | -7.6 kg (-16.8 lbs) | 27% of patients |
| Tirzepatide 10 mg | 469 | -2.24% (difference vs semag -0.39%) | -9.3 kg (-20.5 lbs) | 40% of patients |
| Tirzepatide 15 mg | 470 | -2.30% (difference vs semag -0.45%) | -11.2 kg (-24.7 lbs) | 46% of patients |
| Semaglutide 1.0 mg | 469 | -1.86% (reference active comparator) | -5.7 kg (-12.6 lbs) | 19% of patients |
Mounjaro Stepwise Titration Schedule
Mounjaro is administered once weekly at any time of day, with or without food. The dose escalation protocol minimizes gastrointestinal adverse effects while titrating to individual therapeutic glycemic goals:
| Step | Timing | Weekly Dose | Clinical Directive |
|---|---|---|---|
| Initiation | Weeks 1–4 | 2.5 mg weekly | Starting dose for treatment initiation; not effective for glycemic control alone. |
| Dose Tier 1 | Weeks 5–8 | 5.0 mg weekly | Initial glycemic maintenance dose; significant HbA1c drop. |
| Dose Tier 2 | Weeks 9–12 | 7.5 mg weekly | Optional intermediate escalation step if A1C remains elevated. |
| Dose Tier 3 | Weeks 13–16 | 10.0 mg weekly | Advanced therapeutic maintenance tier. |
| Dose Tier 4 | Weeks 17–20 | 12.5 mg weekly | High-potency glycemic control tier. |
| Maximum Dose | Week 21+ | 15.0 mg weekly | Maximum approved maintenance dose for intensive glycemic management. |
Transform Your Glycemic Health with Mounjaro
Flat $1,399/mo rate across all six doses. Save up to $100 on your first month order. Comprehensive doctor oversight and free cold-chain express shipping.
See If You QualifyFDA Safety Profile & Boxed Warning
Mounjaro carries an FDA Boxed Warning for Thyroid C-Cell Tumors. In rodent carcinogenicity studies, tirzepatide caused dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures.
BOXED WARNING & PRECAUTIONS
- Contraindicated in patients with personal or family history of Medullary Thyroid Carcinoma (MTC).
- Contraindicated in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Contraindicated in patients with known serious hypersensitivity to tirzepatide.
- Not indicated for use in type 1 diabetes mellitus or for treating diabetic ketoacidosis.
In SURPASS-2, the most frequent adverse events were gastrointestinal: nausea (17.4%–22.1%), diarrhea (13.3%–13.8%), vomiting (5.7%–9.8%), and constipation (5.8%–6.4%). Treatment discontinuation due to adverse events was 6.0% (5mg), 8.5% (10mg), and 8.5% (15mg) vs 4.1% for semaglutide 1.0 mg.
How the Telehealth FX Mounjaro Program Works
Complete Metabolic Intake
Answer questions regarding your diabetes diagnosis, current HbA1c levels, renal health, and concomitant medications.
Board-Certified MD Evaluation
A licensed physician reviews your medical history, verifies your clinical indication, and creates your individualized titration protocol.
Express Cold-Chain Delivery
Your authentic Eli Lilly Mounjaro single-dose pens ship in insulated, temperature-controlled packaging with 2-day delivery.
Continuous Glycemic Monitoring
Ongoing physician consultations and regular A1C tracking ensure your blood sugar reaches optimal targets with minimal side effects.
Frequently Asked Questions
What is Mounjaro and what is its primary FDA indication?
Mounjaro® (tirzepatide) is an FDA-approved prescription medication indicated as an adjunct to diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes mellitus. It is the first once-weekly dual GIP and GLP-1 receptor agonist approved in the United States.
How much does Mounjaro cost through Telehealth FX?
Through Telehealth FX, authentic Mounjaro is available at a flat rate of $1,399 per month across all dosage strengths (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg). First-time orders receive an automatic discount saving up to $100 at checkout ($1,299 for your first month). The fee includes your licensed physician evaluation, titration oversight, and temperature-controlled 2-day cold shipping.
How did Mounjaro compare to Ozempic (semaglutide) in the SURPASS-2 trial?
In the SURPASS-2 head-to-head trial (NEJM 2021, n=1,879), tirzepatide 15 mg proved statistically superior to semaglutide 1.0 mg in both HbA1c reduction (-2.30% vs -1.86%, p<0.001) and mean body weight reduction (-11.2 kg vs -5.7 kg, p<0.001). Up to 46% of patients on tirzepatide reached normoglycemia (HbA1c < 5.7%) compared to 19% on semaglutide.
What is the recommended Mounjaro titration schedule?
Mounjaro begins at 2.5 mg injected subcutaneously once weekly for 4 weeks to establish tolerability. At week 5, the dose increases to 5.0 mg weekly. If additional glycemic control is required, doses can be increased in 2.5 mg increments after at least 4 weeks on the current dose, through 7.5 mg, 10.0 mg, 12.5 mg, up to a maximum of 15.0 mg once weekly.
Can Mounjaro be used in patients with type 1 diabetes?
No. Mounjaro is not indicated for and should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis, as it relies on stimulating endogenous pancreatic insulin production.
Can I pay for Mounjaro using HSA or FSA accounts?
Yes. Mounjaro is an FDA-approved clinical prescription medicine for type 2 diabetes. All medication and physician fees qualify as medical expenses under IRS Section 213(d) and can be paid directly with an HSA/FSA debit card.
Real Patient Reviews & Clinical Outcomes
"SURPASS-2 data convinced me to choose Mounjaro over semaglutide. A1C dropped from 8.1% to 5.4% and lost 31 lbs. Telehealth FX physician care is top-tier."
"Fast medical assessment, same-day approval, and prompt arrival. The dual incretin mechanism provided immediate metabolic improvements."
Start Your Mounjaro Program Today
$1,399/mo flat rate across all doses. Save up to $100 on your first month order. Board-certified physician oversight. Free cold-chain express delivery.
Claim $100 Off First Order